EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Pancreatitis in cystic fibrosis: Presentation, medical and surgical management, and the impact of modulator therapies

Reza V Milano, Kayla Morneault-Gill, Hebat Y Kamal, Jodie A Barkin iD, Christina Baldwin Chadwick iD

Pediatric Pulmonology · 2024

DOI: 10.1002/ppul.26958 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pediatric Pulmonology, 2024. Verfasst von Reza V Milano und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Digestive Health and Liver Diseases, University of Miami, Leonard M. Miller School of Medicine, Miami, Florida, U…. Hauptthemen laut MEDLINE: Cystic Fibrosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with Cystic Fibrosis (CF) are at increased risk of acute (AP) and chronic (CP) pancreatitis, and their complications. The extent of remaining healthy pancreatic parenchyma determines the risk of developing future episodes of pancreatitis, as well as pancreatic exocrine or endocrine insufficiency. Pancreatitis may be the presenting symptom of CF, and genetic testing is especially important in pediatrics. AP and recurrent AP are managed with intravenous fluid hydration and pain control, in addition to early refeeding and treatment of complications. With the use of modulator therapy in CF, pancreatic function may be restored to some extent. CP related pain is managed with analgesics and neuromodulators, with surgery if indicated in specific situations including TPIAT as a possible type of surgical intervention. Long‐term sequelae of CP in patients with CF include exocrine pancreatic insufficiency treated with pancreatic enzyme replacement therapy, fat‐soluble vitamin deficiencies and associated metabolic complications such as bone disease/osteoporosis, pancreatogenic diabetes, and less commonly, pancreatic cancer. We review the presentation and etiologies of pancreatitis in CF patients as well as the management of AP and CP primarily in children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisHumansChildPancreatitisEnzyme Replacement TherapyExocrine Pancreatic InsufficiencyPancreatitis, Chronic

Stichwörter der Autor:innen

acute pancreatitiscystic fibrosismanagementmodulatorpancreatitis

Autor:innen und Institutionen

  • Department of Medicine, Division of Digestive Health and Liver Diseases, University of Miami, Leonard M. Miller School of Medicine, Miami, Florida, USA.
  • Department of Pediatrics, Division of Gastroenterology, University of Florida, College of Medicine, Gainesville, Florida, USA.

ORCID-Profile: Jodie A Barkin, Christina Baldwin Chadwick

Förderung

  • None

Zitieren

APA

Milano, R. V., Morneault-Gill, K., Kamal, H. Y., Barkin, J. A., & Chadwick, C. B. (2024). Pancreatitis in cystic fibrosis: Presentation, medical and surgical management, and the impact of modulator therapies. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26958

Vancouver

Milano RV, Morneault-Gill K, Kamal HY, Barkin JA, Chadwick CB. Pancreatitis in cystic fibrosis: Presentation, medical and surgical management, and the impact of modulator therapies. Pediatric Pulmonology. 2024. doi:10.1002/ppul.26958

BibTeX
@article{Milano2024,
  author = {Milano, Reza V and Morneault-Gill, Kayla and Kamal, Hebat Y and Barkin, Jodie A and Chadwick, Christina Baldwin},
  title = {Pancreatitis in cystic fibrosis: Presentation, medical and surgical management, and the impact of modulator therapies},
  journal = {Pediatric Pulmonology},
  year = {2024},
  doi = {10.1002/ppul.26958}
}
Kostenlos starten →